Cosmo Pharmaceuticals N.V. (0RGI.L) Dividend Yield, History & Forecast

Cosmo Pharmaceuticals N.V. (0RGI.L) is a Medical - Pharmaceuticals company in the Healthcare sector listed on the London Stock Exchange. It pays a current dividend yield of 2.59% ($2.10 per share annually (TTM)), with 3 years of consecutive dividend increases. The most recent ex-dividend date was April 24, 2026, with payment scheduled for May 11, 2026. market capitalization is approximately $1.41B.

Loading quote...

Frequently Asked Questions about Cosmo Pharmaceuticals N.V. (0RGI.L)

What is Cosmo Pharmaceuticals N.V.'s dividend yield?
Cosmo Pharmaceuticals N.V. (0RGI.L) pays a current trailing twelve-month dividend yield of 2.59%, which works out to $2.10 per share annually based on the most recent payout schedule.
When does Cosmo Pharmaceuticals N.V. pay its next dividend?
The most recent ex-dividend date was April 24, 2026. The next scheduled dividend payment date is May 11, 2026.
How many years has Cosmo Pharmaceuticals N.V. increased its dividend?
Cosmo Pharmaceuticals N.V. (0RGI.L) has increased its dividend for 3 consecutive years.
Is Cosmo Pharmaceuticals N.V. a Dividend Aristocrat?
No. Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. Cosmo Pharmaceuticals N.V. (0RGI.L) currently has 3 years of consecutive increases.
What sector is Cosmo Pharmaceuticals N.V. in?
Cosmo Pharmaceuticals N.V. (0RGI.L) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry.